Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Enzon Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

28 Oct 2016 Reuters Investment Profile 12 $20.00

ENZN: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

02 Nov 2016 New Constructs, LLC 10 $25.00

"The Economy Matters" Report for ENZN: the economy's impact on ENZN's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

01 Nov 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

Value Graph: ENZON PHARMACEUT -- ENZN

28 Oct 2016 Ford Investor Services, Inc. 1 $12.00

Enzon Pharmaceuticals

22 Oct 2016 S&P Capital IQ Quantitative Report 10 $115.00

Wright Investors Service Comprehensive Report for Enzon Pharmaceuticals, Inc.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

07 Oct 2016 Wright Reports 64 $75.00

Enzon Pharmaceuticals, Inc.

Enzon Pharmaceuticals, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The repor...

05 Oct 2016 MarketLine 29 $50.00

Enzon Pharmaceuticals, Inc. (ENZN) - Financial and Strategic SWOT Analysis Review

Enzon Pharmaceuticals, Inc. (ENZN) - Financial and Strategic SWOT Analysis Review Summary Enzon Pharmaceuticals, Inc. (Enzon)...

04 Oct 2016 GlobalData 48 $300.00

Enzon Pharmaceuticals, Inc. (ENZN) - Financial and Strategic SWOT Analysis Review

Enzon Pharmaceuticals, Inc. (ENZN) - Financial and Strategic SWOT Analysis Review Summary Enzon Pharmaceuticals, Inc. (Enzon)...

19 Sep 2016 GlobalData 50 $300.00

Enzon Pharmaceuticals Inc: Downgraded to Average

02 May 2016 Sadif Analytics Prime 3 $10.00